Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis

被引:58
作者
Macchi, B
Matteucci, C
Nocentini, U
Caltagirone, C
Mastino, A
机构
[1] Univ Roma Tor Vergata, Dept Neurosci, I-00133 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy
[3] IRCCS, Clin S Lucia, Rome, Italy
[4] Univ Messina, Fac Sci, Inst Microbiol, Messina, Italy
关键词
activation-induced cell death; apoptosis; Bcl-2; demyelination; Fas; multiple sclerosis; PHA;
D O I
10.1097/00001756-199902050-00034
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
WE investigated the sensitivity to cell death of peripheral blood mononuclear cells (PBMCs) from patients with multiple sclerosis (MS). PBMCs from MS patients, following PHA stimulation, were less sensitive to cell death than those from healthy donors (mean +/- s.e.m., 22.5 +/- 1.9 in MS patients ws 36.5 +/- 2.8 in healthy controls; p = 0.0003). However, when Fas-agonist antibody was added, the increase in respect to apoptosis induced by mitogen alone was even higher in MS patients than in controls. In addition, PHA-activated PBMCs from MS patients showed higher surface expression of Fas than controls, while Bcl-2 expression was decreased. This finding raised the question of whether an impaired generation of apoptotic signals may be contributing to the immune component of MS. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:399 / 402
页数:4
相关论文
共 25 条
[1]
Serum sAPO-1/Fas levels in multiple sclerosis [J].
Bansil, S ;
Holtz, CR ;
Cook, SD ;
RohowskyKochan, C .
ACTA NEUROLOGICA SCANDINAVICA, 1997, 95 (04) :208-210
[2]
Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis [J].
Bonetti, B ;
Raine, CS .
ANNALS OF NEUROLOGY, 1997, 42 (01) :74-84
[3]
Mechanisms of immune injury in multiple sclerosis [J].
Brosnan, CF ;
Raine, CS .
BRAIN PATHOLOGY, 1996, 6 (03) :243-257
[4]
Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients [J].
Ciusani, E ;
Frigerio, S ;
Gelati, M ;
Corsini, E ;
Dufour, A ;
Nespolo, A ;
La Mantia, L ;
Milanese, C ;
Massa, G ;
Salmaggi, A .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 82 (01) :5-12
[5]
Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity [J].
De Maria, R ;
Testi, R .
IMMUNOLOGY TODAY, 1998, 19 (03) :121-125
[6]
Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain [J].
Dowling, P ;
Shang, GF ;
Raval, S ;
Menonna, J ;
Cook, S ;
Husar, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1513-1518
[7]
Multiple sclerosis: Fas signaling in oligodendrocyte cell death [J].
DSouza, SD ;
Bonetti, B ;
Balasingam, V ;
Cashman, NR ;
Barker, PA ;
Troutt, AB ;
Raine, CS ;
Antel, JP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) :2361-2370
[8]
Ferrante P, 1998, J IMMUNOL, V160, P1514
[9]
Increased Fas antigen on T cells in multiple sclerosis [J].
Ichikawa, H ;
Ota, K ;
Iwata, M .
JOURNAL OF NEUROIMMUNOLOGY, 1996, 71 (1-2) :125-129
[10]
MARTIN R, 1990, J IMMUNOL, V145, P540